Adipocyte dysfunction and hypertension

Area of Science:

• Cardiovascular Science
• Endocrinology
• Metabolic Disease

Background:

• Obesity is a major public health concern linked to numerous comorbidities, including hypertension.
• The relationship between obesity and hypertension is established, but underlying cellular and molecular mechanisms require further elucidation.
• Adipose tissue plays a critical role in metabolic regulation and cardiovascular health through its endocrine and paracrine functions.

Purpose of the Study:

• To review recent advancements in understanding the cellular and molecular mechanisms linking obesity-induced adipocyte dysfunction to hypertension.
• To explore the roles of adipose tissue-derived adipokines in modulating vascular cell and macrophage function in the context of hypertension.

Main Methods:

• Literature review of recent studies on obesity, adipocyte dysfunction, and hypertension.
• Analysis of cellular and molecular mechanisms involving adipokines.
• Examination of the effects of adipokines on vascular endothelial cells, smooth muscle cells, and macrophages.

Main Results:

• Adipocyte dysfunction in obesity leads to altered secretion of adipokines.
• These adipokines exert endocrine and paracrine effects that impact vascular homeostasis.
• Dysfunctional adipokines contribute to hypertension by affecting vascular endothelial cells, smooth muscle cells, and macrophages.

Conclusions:

• Adipocyte dysfunction in obesity is a significant contributor to hypertension development.
• Understanding the adipokine-mediated pathways offers potential therapeutic targets for managing obesity-related hypertension.
• Further research into these cellular and molecular mechanisms is crucial for effective intervention strategies.